about
Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS.Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patientsSerum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients.Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.Early Mortality Was Highly and Strongly Associated with Functional Status in Incident Japanese Hemodialysis Patients: A Cohort Study of the Large National Dialysis Registry.Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: results from the MBD-5D studyDevelopment and Validation of a Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient SettingsReduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study.PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidismVascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study.Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS.Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits.Peritoneal Dialysis Registry With 2012 Survey Report.Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers.Indication and efficacy of PEIT in the management of secondary hyperparathyroidism.Peritoneal Dialysis Registry With 2013 Survey Report.Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS.Influence of acute kidney injury on the time to complete remission in adult minimal change nephrotic syndrome: a single-centre study.Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.An overview of regular dialysis treatment in Japan (as of 31 December 2012).Overview of regular dialysis treatment in Japan (as of 31 December 2008).An overview of regular dialysis treatment in Japan (as of 31 December 2007).Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin.Overview of regular dialysis treatment in Japan (as of 31 December 2009).Overview of regular dialysis treatment in Japan (as of 31 December 2011).Adult staphylococcus scalded skin syndrome in a peritoneal dialysis patient.Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.Association between post-dialysis hemoglobin level and the survival of vascular access.Interpersonal psychosocial factors associated with underreported dietary energy intake in hemodialysis patients.Sperm-associated antigen 4, a novel hypoxia-inducible factor 1 target, regulates cytokinesis, and its expression correlates with the prognosis of renal cell carcinoma.Practice pattern of physician's directions of exercise restriction in patients with chronic kidney disease: results from the Chronic Kidney Disease Japan Cohort study.Anemia and Long-Term Renal Prognosis in Patients with Post-Renal Acute Kidney Injury of Nonmalignant Cause.Erythropoietin Hyporesponsiveness in Dialysis Patients: Possible Role of Statins.Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data RegistryAssociation between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design
P50
Q33801077-CD13B598-CF62-4304-9B29-61C5C5D863B5Q34292935-EA5B05AF-0918-4E6B-AF2C-9C9BD7A1D797Q34555348-B2AF08B5-CF68-4923-913F-E862F0FA7D1EQ35940980-887ADF1D-F1A6-498F-850E-E0A12ACDE694Q35983513-7E3412A5-B45C-488A-AFEE-D486BB5820B9Q36043210-553CD70E-34C3-4E39-B03E-B7EF44E0FDF9Q36199558-5E9E903D-F7F7-47F4-9A80-FC666273C65BQ36247702-E2D34396-C914-4559-B83A-A76ECEF5F2C4Q36740987-FD1E1CF2-C008-4694-8CFF-9FDE765F4CCFQ36793098-1315CBD9-C912-44F2-AF56-1851EB23B1FFQ36889892-FF387958-235E-4E52-8A7A-9C0F8A19CCFCQ36938864-C7A2F876-2614-4316-8724-BB3CC86D4771Q37123192-607CED4C-239B-4E75-82E9-6BCBD2CFC51AQ40106849-390A137A-61E2-4C2C-99C1-15B9C03488A4Q40215267-D6124CB6-4E41-4E19-973A-435E119FFD0DQ40318401-6D15BB8B-5B87-4929-B705-2D1E5337970EQ40391412-2B43DFEC-B276-42AC-9702-9D1EF9EF2BEEQ40715073-D528C7AF-B16A-4E35-B373-21C8461D505BQ41099254-DB645CCE-512D-46AE-9657-F35BC5F433BAQ41496856-E099F323-A01D-41C1-982D-8F81EC03F535Q41670601-B607332A-A1E6-41C8-8ED5-69431C522B0AQ42789867-D5B9D667-03DC-4619-BC37-9CDC3F39B48AQ43232033-7D83D0B1-14AB-4EB7-AEC7-2FD7BD670548Q43591504-9A5DCF26-6039-4018-BC74-DE0B7E4B20D0Q43610757-2E491670-49E9-464A-8C8D-CBCB37638266Q44632924-DCDF8606-7C66-43A8-A6B3-5D6CEA738247Q44637610-8B301112-CD7F-45D2-B31A-D37F0AF1FF9FQ46575588-62F8299D-9366-4A02-8A64-46AADFCC5D77Q47688794-6F335D6A-88C3-49D0-BC61-A94B5FE36C0CQ47705828-933E7870-8164-4516-BA44-04D999C93CAEQ48715081-47647EC1-1149-4BD9-8FF6-DBB552F965F6Q51058107-0B7A7E39-AC36-4086-AC3E-3240470864ADQ52647362-7388A5F7-8D1B-4116-8AB8-571708769EEAQ53631418-8C845654-C5C3-49AB-BE86-C9B979ACAB98Q53738394-C156826A-9EFD-43BA-93F3-1A9F2E01F029Q54658458-CE718AA0-61EC-4E74-AC8E-C67BE60D3409Q57623222-D3E636BE-9068-451F-BCA6-442290F453DCQ61798493-86EEC59E-500E-4A42-8564-22B855E000D4Q64951055-E14F68FE-5C52-4306-826E-32C7D5A5258CQ83680407-12D0A108-0C23-4774-AC5A-7E97311E0E87
P50
description
hulumtues
@sq
researcher
@en
հետազոտող
@hy
name
Takeshi Hasegawa
@ast
Takeshi Hasegawa
@en
Takeshi Hasegawa
@es
Takeshi Hasegawa
@nl
Takeshi Hasegawa
@sl
type
label
Takeshi Hasegawa
@ast
Takeshi Hasegawa
@en
Takeshi Hasegawa
@es
Takeshi Hasegawa
@nl
Takeshi Hasegawa
@sl
prefLabel
Takeshi Hasegawa
@ast
Takeshi Hasegawa
@en
Takeshi Hasegawa
@es
Takeshi Hasegawa
@nl
Takeshi Hasegawa
@sl
P106
P1153
35432139900
P21
P31
P496
0000-0003-0420-5583